Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1998;32:862-868

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferri, C.
Right arrow Articles by Santucci, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferri, C.
Right arrow Articles by Santucci, A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL
Medline Plus Health Information
*Dietary Sodium
*High Blood Pressure

(Hypertension. 1998;32:862-868.)
© 1998 American Heart Association, Inc.


Scientific Contributions

Clustering of Endothelial Markers of Vascular Damage in Human Salt-Sensitive Hypertension

Influence of Dietary Sodium Load and Depletion

Claudio Ferri; Cesare Bellini; Giovambattista Desideri; Elisabetta Giuliani; Luca De Siati; Sabrina Cicogna; ; Anna Santucci

From the University "La Sapienza," Chair of I Clinica Medica, Andrea Cesalpino Foundation (C.F., G.D., L. De S.), and Departments of Experimental Medicine (C.B.) and Internal Medicine and Cardiology (E.G., S.C., A.S.), University of L'Aquila, L'Aquila, Italy.

Correspondence to Claudio Ferri, MD, Università "La Sapienza, " Cattedra di I Clinica Medica, Fondazione Andrea Cesalpino, Viale del Policlinico 155, 00161 Roma, Italy. E-mail clferri{at}axrma.uniroma1.it

Abstract—The contributing role of vascular endothelium in the development of hypertension-related vascular damage is well accepted. Salt-sensitive hypertension is characterized by a cluster of renal, hormonal, and metabolic derangements that might favor the development of cardiovascular and renal damage. To evaluate endothelial involvement in salt-sensitive essential hypertension, plasma levels of several markers of endothelial damage such as endothelin-1 (ET-1), von Willebrand factor (vWf), and soluble (S-) adhesion molecules E-selectin, intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and 24-hour urinary albumin excretion (UAE) were measured in 39 nondiabetic, nonobese, never-treated essential hypertensive patients after intermediate (120 mmol/d), high (220 mmol/d), and low (20 mmol/d) NaCl diets. Patients were classified as salt sensitive (n=18) or salt resistant (n=21) according to their blood pressure responses to changes in dietary NaCl intake. Salt-sensitive hypertensives showed higher plasma ET-1 (P<0.05), vWf (P<0.005), and S-E-selectin levels (P<0.04) and increased UAE (P<0.05) than salt-resistant hypertensives. By contrast, circulating S-ICAM-1 and S-VCAM-1 concentrations were not significantly higher in salt-sensitive (596.56±177.05 ng/mL and 541.06±157.84 ng/mL, respectively) than salt-resistant patients (516.86±147.99 ng/mL and 449.48±158.91 ng/mL, respectively). During the intermediate NaCl diet, plasma ET-1 responses to oral glucose load were greater in salt-sensitive (P<0.05) than in salt-resistant patients. A marked (P<0.05) hyperinsulinemic response to oral glucose load was evident in salt-sensitive but not salt-resistant patients after each diet. This study shows increased plasma levels of the endothelium-derived substances E-selectin, vWf, and ET-1 in salt-sensitive hypertensives. Our findings support the hypothesis that salt sensitivity is correlated with an increased risk for developing hypertension-related cardiovascular damage.


Key Words: endothelium • cell adhesion molecules • vasorelaxation • sodium • blood pressure




This article has been cited by other articles:


Home page
The Annals of PharmacotherapyHome page
B. J Epstein
Efficacy and Safety of Darusentan: A Novel Endothelin Receptor Antagonist
Ann. Pharmacother., July 1, 2008; 42(7): 1060 - 1069.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. D. Imig
Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases
Am J Physiol Renal Physiol, September 1, 2005; 289(3): F496 - F503.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
C. P. del Villar, C. J. G. Alonso, C. A. Feldstein, L. A. Juncos, and J. C. Romero
Role of Endothelin in the Pathogenesis of Hypertension
Mayo Clin. Proc., January 1, 2005; 80(1): 84 - 96.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. R. Sowers
Insulin resistance and hypertension
Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1597 - H1602.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. Li, Y. Chu, G. D. Fink, J. F. Engelhardt, D. D. Heistad, and A. F. Chen
Endothelin-1 Stimulates Arterial VCAM-1 Expression Via NADPH Oxidase-Derived Superoxide in Mineralocorticoid Hypertension
Hypertension, November 1, 2003; 42(5): 997 - 1003.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. A. Preston, W. Jy, J. J. Jimenez, L. M. Mauro, L. L. Horstman, M. Valle, G. Aime, and Y. S. Ahn
Effects of Severe Hypertension on Endothelial and Platelet Microparticles
Hypertension, February 1, 2003; 41(2): 211 - 217.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
R. Pedrinelli, G. Dell'Omo, G. Penno, and M. Mariani
Non-diabetic microalbuminuria, endothelial dysfunction and cardiovascular disease
Vascular Medicine, November 1, 2001; 6(4): 257 - 264.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. I. McFarlane, M. Banerji, and J. R. Sowers
Insulin Resistance and Cardiovascular Disease
J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 713 - 718.
[Full Text]


Home page
CirculationHome page
F. Elijovich, C. L. Laffer, E. Amador, H. Gavras, M. R. Bresnahan, and E. L. Schiffrin
Regulation of Plasma Endothelin by Salt in Salt-Sensitive Hypertension
Circulation, January 16, 2001; 103(2): 263 - 268.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Desideri, A. Gaspardone, M. Gentile, A. Santucci, P. A. Gioffre, and C. Ferri
Endothelial Activation in Patients With Cardiac Syndrome X
Circulation, November 7, 2000; 102(19): 2359 - 2364.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Di Gennaro, A. Barilli, C. Giuffredi, C. Gatti, A. Montanari, and P. P. Vescovi
Sodium Sensitivity of Blood Pressure in Long-Term Detoxified Alcoholics
Hypertension, April 1, 2000; 35(4): 869 - 874.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. Pastore, A. Tessitore, S. Martinotti, E. Toniato, E. Alesse, M. C. Bravi, C. Ferri, G. Desideri, A. Gulino, and A. Santucci
Angiotensin II Stimulates Intercellular Adhesion Molecule-1 (ICAM-1) Expression by Human Vascular Endothelial Cells and Increases Soluble ICAM-1 Release In Vivo
Circulation, October 12, 1999; 100(15): 1646 - 1652.
[Abstract] [Full Text] [PDF]